You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
Metabolic Complications Cardiovascular Disease / Cholesterol Triglycerides / Diabetes / Insulin Resistance / Hyperlipidemia / Myocardial Infarction
More Evidence Abacavir Does Not Raise Heart Attack Risk 4-18-2011 Risk of Strokes Is Increasing for People with HIV 1-28-2011 Elevated Triglyceride Level Increases Likelihood of Peripheral Neuropathy 1-11-2011 Effectiveness of Statins among HIV Positive People on Antiretroviral Therapy 1-11-2011 HIV Infection Linked to Increased Cardiovascular Risk Even in Long-term Non-progressors 9-17-2010 Traditional Risk Factors Predict Cardiovascular Risk in People with HIV 8-31-2010 HIV Positive People Could Benefit from Aspirin to Reduce Cardiovascular Risk 8-31-2010 METABOLIK (Metabolic Evaluation in Treatment-naïves Assessing the impact of two Boosted protease inhibitors on LIpids and other marKers): Comparison of the Metabolic Effects of Darunavir/ritonavir versus Atazanavir/ritonavir over 12Weeks 7-23-2010 Darunavir/ritonavir increases rosuvastatin concentrations but does not alter lipid lowering effect in healthy volunteers 7-09-2010 Late Antiretroviral Therapy Raises Risk of Early Atherosclerosis 7-09-2010 Pentoxifylline May Improve Endothelial Dysfunction in People with HIV 7-09-2010 Niacin May Improve Blood Vessel Function in People with HIV 5-25-2010 Cholesterol Crystals Trigger Inflammation Leading to Atherosclerosis 5-25-2010 People with HIV Often Have Elevated Homocysteine Levels during Antiretroviral Treatment 4-27-2010 Switching to Atazanavir (Reyataz) Lowers Cholesterol and Triglycerides, but No Improvement in Artery Function 4-6-2010 Heavy Alcohol Use Increases Risk of Cardiovascular Disease in Men with HIV 4-2-2010 Metabolic Profiles and Body Composition Changes in Treatment-Naïve HIV-Infected Patients Treated with Raltegravir 400 mg bid-based vs. Efavirenz 600 mg qhs-based Combination Therapy: 96-Week Follow-Up 2-23-2010 Body Composition and Metabolic Changes in the SMART Treatment Interruption Trial 2-16-2010 Progestin-only Hormonal Contraception Linked to Lower HDL Levels and More Insulin Resistance in Women with HIV 1-19-2010 Some Antiretroviral Drugs Linked to Heart Attacks in D:A:D Study, but Overall Risk Remains Small 1-15-2010 HIV Positive Men Have More Atherosclerosis and Higher Vascular Age than Uninfected Men 1-15-2010 Persistent Detectable HIV Viral Load Is Linked to Metabolic Syndrome 12/11/09 Traditional Cardiovascular Risk Factors Strongly Predict Likelihood of Myocardial Infarction in People with HIV 12/01/09 Effective Antiretroviral Therapy Leads to Improved Lung Function in People with HIV 10/09/09 HIV Infection Sharply Increases Risk of Atherosclerosis, but Antiretroviral Therapy Has a Minor Effect 9/11/09 Artery Elasticity Is Reduced in People with Untreated HIV Infection 9/11/09 Confounding Factors May Explain Elevated Cardiovascular Risk in Patients Taking Abacavir 7/28/09 Nevirapine (Viramune) Has Equal Efficacy but a More Favorable Lipid Profile Compared with Boosted Atazanavir (Reyataz) 7/28/09 Intensive Cardiovascular Intervention Lowers Blood Lipids in HIV Patients on Antiretroviral Therapy 7/24/09 Switching from Lopinavir/ritonavir (Kaletra) to Boosted Atazanavir (Reyataz) Reduces Visceral Fat and Improves Glucose Metabolism 7/10/09 Ongoing HIV Replication during Treatment Interruption Is Associated with Inflammatory and Cardiovascular Risk Markers 6/5/09 GlaxoSmithKline Meta-analysis Does Not Show Elevated Cardiovascular Risk Associated with Use of abacavir (Ziagen, Epzicom) 5/19/09 Metabolic and Body Shape Abnormalities Are Common in Children and Youth with HIV 5/15/09 Natural Hormone Leptin Improves Blood Lipid Levels and Insulin Sensitivity and Decreases Abdominal Fat in People with HIV 5/08/09 Study Shows High Prevalence of Metabolic Syndrome and Associated Cardiovascular Risk in Older HIV Patients 1/13/09 Ezetimibe (Zetia) Reduces Bad LDL Cholesterol in HIV Positive People on HAART 10/17/08 Blood Lipid Profiles Improve after CD4-guided Treatment Interruption 9/25/08 SMART Researchers Publish Findings Showing Abacavir (Ziagen) Is Associated with Elevated Risk of Cardiovascular Disease 9/09/2008 Management of Elevated Blood Lipids May Be Less Successful in HIV Patients with High Cardiovascular Risk 9/09/2008 Does Raltegravir (Isentress) Worsen Depression in HIV Patients with a History of Treatment for Depression? 9/05/08 Levels of Osteopontin Protein Are Elevated in People with HIV-associated Dementia 9/05/08 FDA Announces Changes to Ritonavir (Norvir) Label to Reflect New Data on Heart Rhythm Abnormalities 9/05/08 Coronary Heart Disease, HIV Infection, and Antiretroviral Therapy 8/22/08 Studies Look at Association between CD4 Cell Count and Cardiovascular Risk in People with HIV 8/22/08 Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08 Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08 Experts Recommend Cardiovascular Risk Screening for People with HIV 7/08/08 HIV Positive Children and Adolescents Have Elevated Risk of Cardiovascular Disease 7/08/08 Studies Find Minimal Cardiovascular Benefit and Increased Mortality with Intensive Glucose Management for People with Type 2 Diabetes 6/20/08 High-density Lipoprotein (HDL) Cholesterol in People with HIV: Association with Viral Load and Antiretroviral Therapy 6/03/08 Ezetimibe Combined with Low-dose Statin Drugs Effectively Reduces Low Density Lipoprotein (LDL) in HIV Patients on Protease Inhibitors 6/03/08 Controlling Cholesterol with Statins 5/23/08 Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? 5/16/08 Body Fat and Blood Lipid Levels in Men and Women with HIV 5/16/08 Body Shape Changes in HIV Positive and HIV Negative Women 5/16/08
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks 5/13/08 Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect 5/13/08 Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies 5/09/08
